Diabetes and cardiovascular events in women with polycystic ovary syndrome: A 20-year retrospective cohort study

Clinical Endocrinology

Volumn 78, Issue 6, 2013, Pages 926-934

  Mani, Hamidreza ^a,b   Levy, Miles J ^b   Davies, Melanie J ^a,b   Morris, Danielle H ^a   Gray, Laura J ^c   Bankart, John ^c   Blackledge, Hannah ^a,b,d   Khunti, Kamlesh ^c   Howlett, Trevor A ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d LEICESTER CITY COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING;

ADULT; ANGINA PECTORIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HEART FAILURE; HUMANS; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYCYSTIC OVARY SYNDROME; PREVALENCE; RETROSPECTIVE STUDIES; STROKE;

EID: 84876514085     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12068     Document Type: Article

References (36)

1. Azziz, R., Carmina, E., Dewailly, D., et al,. (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility, 91, 456-488.
2. March, W.A., Moore, V.M., Willson, K.J., et al,. (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction, 25, 544-551.
3. Legro, R.S., Castracane, V.D., &, Kauffman, R.P., (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstetrical & Gynecological Survey, 59, 141-154.
4. Dunaif, A., (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews, 18, 774-800.
5. Ehrmann, D.A., Barnes, R.B., Rosenfield, R.L., et al,. (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care, 22, 141-146.
6. Legro, R.S., Kunselman, A.R., Dodson, W.C., et al,. (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism, 84, 165-169.
7. Moran, L.J., Misso, M.L., Wild, R.A., et al,. (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update, 16, 347-363.
8. Toulis, K.A., Goulis, D.G., Mintziori, G., et al,. (2011) Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Human Reproduction Update, 17, 741-760.
9. Wild, R.A., Carmina, E., Diamanti-Kandarakis, E., et al,. (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. Journal of Clinical Endocrinology and Metabolism, 95, 2038-2049.
10. Solomon, C.G., Hu, F.B., Dunaif, A., et al,. (2002) Menstrual cycle irregularity and risk for future cardiovascular disease. Journal of Clinical Endocrinology and Metabolism, 87, 2013-2017.
11. Shaw, L.J., Bairey Merz, C.N., Azziz, R., et al,. (2008) Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. Journal of Clinical Endocrinology and Metabolism, 93, 1276-1284.
12. Chang, A.Y., Ayers, C., Minhajuddin, A., et al,. (2011) Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. Clinical Endocrinology, 74, 89-96.
13. Pierpoint, T., McKeigue, P.M., Isaacs, A.J., et al,. (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. Journal of Clinical Epidemiology, 51, 581-586.
14. Wild, S., Pierpoint, T., McKeigue, P., et al,. (2000) Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clinical Endocrinology, 52, 595-600.
15. Iftikhar, S., Collazo-Clavell, M.L., Roger, V.L., et al,. (2012) Risk of cardiovascular events in patients with polycystic ovary syndrome. Netherlands Journal of Medicine, 70, 74-80.
16. de Groot, P.C.M., Dekkers, O.M., Romijn, J.A., et al,. (2011) PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human Reproduction, 17, 495-500.
17. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81, 19-25.
18. Zawadski, J.K., &, Dunaif, A., (1992) Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In:, A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam, eds. Polycystic Ovary Syndrome. Blackwell Scientific Publications, Boston, MA, 377-384.
19. World-Health-Assembly 4. (2012) International classification of disease. Available at: http://www.who.int/classifications/icd/en/ [Accessed 10 May 2012].
20. Health-Protection-Agency H. (2011) Operation procedure codes. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1215501690196 [Accessed 10 May 2012].
21. Stone, M.A., Camosso-Stefinovic, J., Wilkinson, J., et al,. (2010) Incorrect and incomplete coding and classification of diabetes: a systematic review. Diabetic Medicine, 27, 491-497.
22. de Lusignan, S., Sadek, N., Mulnier, H., et al,. (2012) Miscoding, misclassification and misdiagnosis of diabetes in primary care. Diabetic Medicine, 29, 181-189.
23. World-Health-Organization W. (2011) Definition of obesity. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/ [Accessed 10 May 2012].
24. National-Health-Service H. (2010) Health survey for England. Available at: http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles- related-surveys/health-survey-for-england [Accessed 10 May 2012].
25. Scarborough, P., Bhatnagar, P., Wickramasinghe, K., et al,. (2010) Coronary Heart Disease Statistics 2010. British Heart Foundation Health promotion Research Group, Department of Public Health, University of Oxford.
26. Hippisley-Cox, J., &, Ryan, R., (2007) Diabetes in United Kingdom: analysis of QRESEARCH data. DH 12.
27. Cibula, D., Cifkova, R., Fanta, M., et al,. (2000) Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Human Reproduction, 15, 785-789.
28. Carmina, E., Chu, M.C., Longo, R.A., et al,. (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. Journal of Clinical Endocrinology and Metabolism, 90, 2545-2549.
29. Moran, L., &, Teede, H., (2009) Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Human Reproduction Update, 15, 477-488.
30. Rizzo, M., Berneis, K., Hersberger, M., et al,. (2009) Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Human Reproduction, 24, 2286-2292.
31. Ching, H.L., Burke, V., &, Stuckey, B.G., (2007) Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clinical Endocrinology, 66, 373-379.
32. Glueck, C.J., Dharashivkar, S., Wang, P., et al,. (2005) Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 122, 206-212.
33. Fauser, B.C., &, Bouchard, P., (2011) Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age. Journal of Clinical Endocrinology and Metabolism, 96, 3675-3677.
34. Blackledge, H.M., &, Squire, I.B., (2009) Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004. Heart, 95, 304-311.
35. Carmina, E., Campagna, A.M., &, Lobo, R.A., (2012) A 20-year follow-up of young women with polycystic ovary syndrome. Obstetrics and Gynecology, 119 (2 Pt 1), 263-269.
36. Simpson, E., (1951) The interpretation of interaction in contingency tables. Journal of Royal Statistical Society Series B, 13, 238-241.